US Stock MarketDetailed Quotes

CRMD CorMedix

Watchlist
  • 9.010
  • +0.890+10.96%
Trading Dec 19 14:12 ET
546.70MMarket Cap-11.26P/E (TTM)

CorMedix Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
11.46M
806.12K
0
0
0
0
0
0
-65.74%65.41K
-47.33%29.7K
Operating revenue
--11.46M
--806.12K
--0
--0
--0
--0
--0
--0
-65.74%65.41K
-47.33%29.7K
Cost of revenue
686.6K
509.84K
818.54K
0
0
0
0
0
-97.49%3.73K
-99.15%406
Gross profit
10.77M
296.28K
-818.54K
0
0
0
0
0
46.85%61.67K
249.18%29.3K
Operating expense
34.29%14.06M
32.13%15.6M
44.19%15.89M
59.55%48.96M
86.12%15.67M
50.23%10.47M
42.89%11.8M
56.53%11.02M
4.09%30.69M
8.09%8.42M
Selling and administrative expenses
70.82%13.33M
113.22%14.95M
97.75%15.05M
78.96%35.8M
139.98%13.38M
68.61%7.8M
38.76%7.01M
60.17%7.61M
22.39%20.01M
22.45%5.58M
-Selling and marketing expense
66.29%6.75M
126.87%7.39M
----
----
----
--4.06M
--3.26M
----
----
----
-General and administrative expense
75.73%6.58M
101.38%7.56M
----
----
----
--3.74M
--3.75M
----
----
----
Research and development costs
-72.71%727.12K
-86.42%650.99K
-75.42%837.45K
23.18%13.16M
-19.50%2.29M
13.88%2.66M
49.39%4.79M
48.96%3.41M
-18.68%10.68M
-12.12%2.84M
Operating profit
68.59%-3.29M
-29.62%-15.3M
-51.62%-16.7M
-59.87%-48.96M
-86.77%-15.67M
-50.35%-10.47M
-43.25%-11.8M
-56.66%-11.02M
-4.03%-30.62M
-7.83%-8.39M
Net non-operating interest income expense
-27.69%543.85K
19.56%650.81K
93.63%847.35K
783.99%2.65M
422.80%913.49K
788.61%752.13K
1,614.05%544.33K
5,126.42%437.61K
19,548.12%299.5K
17,382.89%174.73K
Non-operating interest income
-27.62%553.86K
19.48%657.37K
92.03%857.19K
722.61%2.68M
401.37%920.04K
719.17%765.24K
1,456.74%550.18K
3,146.19%446.38K
2,163.53%326.02K
4,102.08%183.51K
Non-operating interest expense
-23.69%10.01K
12.05%6.56K
12.07%9.84K
29.35%34.3K
-25.29%6.56K
49.42%13.11K
63.21%5.85K
63.18%8.78K
66.31%26.52K
63.16%8.78K
Other net income (expense)
-14.13%-33.33K
3,829.26%498.53K
-132.47%-4.01K
-178.06%-28.99K
-77.86%1.23K
-223.87%-29.2K
-173.32%-13.37K
220.96%12.35K
274.50%37.15K
155.17%5.55K
Gain on sale of security
-14.13%-33.33K
88.98%-1.47K
-132.47%-4.01K
-178.06%-28.99K
-77.86%1.23K
-223.87%-29.2K
-173.32%-13.37K
220.96%12.35K
274.50%37.15K
155.17%5.55K
Other non- operating income (expenses)
----
--500K
----
----
----
----
----
----
----
----
Income before tax
71.50%-2.78M
-25.53%-14.15M
-50.10%-15.86M
-53.00%-46.34M
-79.73%-14.75M
-42.18%-9.74M
-37.64%-11.27M
-50.23%-10.57M
-2.81%-30.29M
-5.36%-8.21M
Income tax
0
0
-1.39M
0
0
0
0
0
53.16%-585.62K
0
Net income
71.50%-2.78M
-25.53%-14.15M
-36.90%-14.47M
-56.02%-46.34M
-79.73%-14.75M
-42.18%-9.74M
-48.24%-11.27M
-50.23%-10.57M
-5.29%-29.7M
-5.36%-8.21M
Net income continuous Operations
71.50%-2.78M
-25.53%-14.15M
-36.90%-14.47M
-56.02%-46.34M
-79.73%-14.75M
-42.18%-9.74M
-48.24%-11.27M
-50.23%-10.57M
-5.29%-29.7M
-5.36%-8.21M
Minority interest income
Net income attributable to the parent company
71.50%-2.78M
-25.53%-14.15M
-36.90%-14.47M
-56.02%-46.34M
-79.73%-14.75M
-42.18%-9.74M
-48.24%-11.27M
-50.23%-10.57M
-5.29%-29.7M
-5.36%-8.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
71.50%-2.78M
-25.53%-14.15M
-36.90%-14.47M
-56.02%-46.34M
-79.73%-14.75M
-42.18%-9.74M
-48.24%-11.27M
-50.23%-10.57M
-5.29%-29.7M
-5.36%-8.21M
Basic earnings per share
70.59%-0.05
0.00%-0.25
-4.17%-0.25
-22.97%-0.91
-30.00%-0.26
0.00%-0.17
-31.58%-0.25
-33.33%-0.24
1.33%-0.74
0.00%-0.2
Diluted earnings per share
70.59%-0.05
0.00%-0.25
-4.17%-0.25
-22.97%-0.91
-30.00%-0.26
0.00%-0.17
-31.58%-0.25
-33.33%-0.24
1.33%-0.74
0.00%-0.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 11.46M806.12K000000-65.74%65.41K-47.33%29.7K
Operating revenue --11.46M--806.12K--0--0--0--0--0--0-65.74%65.41K-47.33%29.7K
Cost of revenue 686.6K509.84K818.54K00000-97.49%3.73K-99.15%406
Gross profit 10.77M296.28K-818.54K0000046.85%61.67K249.18%29.3K
Operating expense 34.29%14.06M32.13%15.6M44.19%15.89M59.55%48.96M86.12%15.67M50.23%10.47M42.89%11.8M56.53%11.02M4.09%30.69M8.09%8.42M
Selling and administrative expenses 70.82%13.33M113.22%14.95M97.75%15.05M78.96%35.8M139.98%13.38M68.61%7.8M38.76%7.01M60.17%7.61M22.39%20.01M22.45%5.58M
-Selling and marketing expense 66.29%6.75M126.87%7.39M--------------4.06M--3.26M------------
-General and administrative expense 75.73%6.58M101.38%7.56M--------------3.74M--3.75M------------
Research and development costs -72.71%727.12K-86.42%650.99K-75.42%837.45K23.18%13.16M-19.50%2.29M13.88%2.66M49.39%4.79M48.96%3.41M-18.68%10.68M-12.12%2.84M
Operating profit 68.59%-3.29M-29.62%-15.3M-51.62%-16.7M-59.87%-48.96M-86.77%-15.67M-50.35%-10.47M-43.25%-11.8M-56.66%-11.02M-4.03%-30.62M-7.83%-8.39M
Net non-operating interest income expense -27.69%543.85K19.56%650.81K93.63%847.35K783.99%2.65M422.80%913.49K788.61%752.13K1,614.05%544.33K5,126.42%437.61K19,548.12%299.5K17,382.89%174.73K
Non-operating interest income -27.62%553.86K19.48%657.37K92.03%857.19K722.61%2.68M401.37%920.04K719.17%765.24K1,456.74%550.18K3,146.19%446.38K2,163.53%326.02K4,102.08%183.51K
Non-operating interest expense -23.69%10.01K12.05%6.56K12.07%9.84K29.35%34.3K-25.29%6.56K49.42%13.11K63.21%5.85K63.18%8.78K66.31%26.52K63.16%8.78K
Other net income (expense) -14.13%-33.33K3,829.26%498.53K-132.47%-4.01K-178.06%-28.99K-77.86%1.23K-223.87%-29.2K-173.32%-13.37K220.96%12.35K274.50%37.15K155.17%5.55K
Gain on sale of security -14.13%-33.33K88.98%-1.47K-132.47%-4.01K-178.06%-28.99K-77.86%1.23K-223.87%-29.2K-173.32%-13.37K220.96%12.35K274.50%37.15K155.17%5.55K
Other non- operating income (expenses) ------500K--------------------------------
Income before tax 71.50%-2.78M-25.53%-14.15M-50.10%-15.86M-53.00%-46.34M-79.73%-14.75M-42.18%-9.74M-37.64%-11.27M-50.23%-10.57M-2.81%-30.29M-5.36%-8.21M
Income tax 00-1.39M0000053.16%-585.62K0
Net income 71.50%-2.78M-25.53%-14.15M-36.90%-14.47M-56.02%-46.34M-79.73%-14.75M-42.18%-9.74M-48.24%-11.27M-50.23%-10.57M-5.29%-29.7M-5.36%-8.21M
Net income continuous Operations 71.50%-2.78M-25.53%-14.15M-36.90%-14.47M-56.02%-46.34M-79.73%-14.75M-42.18%-9.74M-48.24%-11.27M-50.23%-10.57M-5.29%-29.7M-5.36%-8.21M
Minority interest income
Net income attributable to the parent company 71.50%-2.78M-25.53%-14.15M-36.90%-14.47M-56.02%-46.34M-79.73%-14.75M-42.18%-9.74M-48.24%-11.27M-50.23%-10.57M-5.29%-29.7M-5.36%-8.21M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 71.50%-2.78M-25.53%-14.15M-36.90%-14.47M-56.02%-46.34M-79.73%-14.75M-42.18%-9.74M-48.24%-11.27M-50.23%-10.57M-5.29%-29.7M-5.36%-8.21M
Basic earnings per share 70.59%-0.050.00%-0.25-4.17%-0.25-22.97%-0.91-30.00%-0.260.00%-0.17-31.58%-0.25-33.33%-0.241.33%-0.740.00%-0.2
Diluted earnings per share 70.59%-0.050.00%-0.25-4.17%-0.25-22.97%-0.91-30.00%-0.260.00%-0.17-31.58%-0.25-33.33%-0.241.33%-0.740.00%-0.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
+3.16%
Halozyme Therapeutics
HALO
+2.16%
Teradata Corp
TDC
+2.03%
Collegium Pharmaceutical
COLL
+1.78%
Lantheus
LNTH
+1.05%

Unlock the Full List